Future Pricing and Reimbursement strategies from ABPI, IMS Health, Baxalta, Shire

from Google Alert at http://bit.ly/29gLijI on June 29, 2016 at 08:27PM


… IGES, Baxalta, Evidera, IGES, Cell & Gene Therapy Catapult, Office of Health Economics, Lundbeck, Novartis, Quintiles, Alcon and many more.